|
|
|
|
LEADER |
01795nam a2200337 u 4500 |
001 |
EB001865333 |
003 |
EBX01000000000000001029413 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
190504 r ||| eng |
100 |
1 |
|
|a Banerjee, Srabani
|
245 |
0 |
0 |
|a Multidisciplinary treatment programs for patients with chronic non-malignant pain
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness, and guidelines
|c Srabani Banerjee, Charlene Argáez
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, June 22, 2017
|
300 |
|
|
|a 1 PDF file (46 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Comparative Effectiveness Research
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Cost-Benefit Analysis
|
653 |
|
|
|a Chronic Pain / therapy
|
653 |
|
|
|a Combined Modality Therapy
|
653 |
|
|
|a Pain Management
|
653 |
|
|
|a Guidelines as Topic
|
700 |
1 |
|
|a Argáez, Charlene
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK525038
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The purpose of this report is to review the comparative clinical effectiveness and costeffectiveness of multidisciplinary treatment programs for patients with chronic, nonmalignant pain in outpatient settings. Additionally, this report aims to review the evidence-based guidelines regarding multidisciplinary treatment programs for patients with chronic, non-malignant pain in outpatient settings
|